4//SEC Filing
Gudkov Andrei V 4
Accession 0001144204-10-021075
CIK 0001318641other
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 4:22 PM ET
Size
11.8 KB
Accession
0001144204-10-021075
Insider Transaction Report
Form 4
Gudkov Andrei V
DirectorChief Scientific Officer
Transactions
- Sale
Common Stock
2010-04-16$3.61/sh−3,900$14,079→ 1,509,600 total - Sale
Common Stock
2010-04-16$3.60/sh−800$2,880→ 1,513,500 total - Sale
Common Stock
2010-04-16$3.62/sh−100$362→ 1,514,300 total - Sale
Common Stock
2010-04-16$3.59/sh−200$718→ 1,514,400 total
Holdings
- 174,750
Employee Stock Options (Right to Buy)
Exercise: $4.00From: 2008-02-04Exp: 2018-02-03→ Common Stock (137,250 underlying) - 37,500
Employee Stock Options (Right to Buy)
Exercise: $8.36From: 2007-04-06Exp: 2017-04-05→ Common Stock (37,500 underlying)
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and represent approximately 0.3% of the reporting person's 1,549,600 shares held prior to adoption of the plan. The maximum sales subject to the plan in its entirety represent approximately 3.9% of the reporting person's shares held prior to adoption of the plan.
Documents
Issuer
CLEVELAND BIOLABS INC
CIK 0001318641
Entity typeother
Related Parties
1- filerCIK 0001370083
Filing Metadata
- Form type
- 4
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 4:22 PM ET
- Size
- 11.8 KB